Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Zhihong Hu Image

      Zhihong Hu, M.D., Ph.D.

      Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2004Loyola University Medical Center, Maywood, Illinois, US, Cellular and Molecular Physiology, Ph.D
      1993Bethune University of Medical Science, Changchun, CN, MD

      Postgraduate Training

      2015-2017Clinical Fellowship, Hematopathology, The University of Texas at MD Anderson Cancer Center (UT-MDACC), Houston, Texas
      2014-2015Clinical Fellowship, Surgical Pathology, Loyola University Medical Center (LUMC), Maywood, Illinois
      2010-2014Clinical Residency, Anatomic Pathology and Clinical Pathology, Loyola University Medical Center (LUMC), Maywood, Illinois
      2005-2006Research Fellowship, The University of Chicago, Chicago, Illinois

      Licenses & Certifications

      2017Texas Medical License
      2016American Board of Pathology, Hematology
      2015American Board of Pathology, Anatomic and Clinical Pathology
      2014Illinois Medical License

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Pathology/Laboratory Medicine, The University of Texas Health Center at Houston, Houston, TX, 2017 - 2022

      Research Associate, Pathology, University of Chicago, Chicago, IL, 2005 - 2006

      Medical Research Scientist, Institute of Space Medico-Engineering of China, Beijing, 1993 - 1999

      Administrative Appointments/Responsibilities

      Research Specialist/Supervisor, Physiology, Loyola University Medical Center (LUMC), Maywood, IL, 2008 - 2010

      Extramural Institutional Committee Activities

      Member, Harris Health System Laboratory Utilization and Stewardship Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, Harris Health Laboratory Supply Equipment and Contracts Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, Harris Health Cancer Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Honors & Awards

      2022Best Investigative Platform Presentation, TSP Annual Meeting
      2022Best Investigative Poster Presentation, TSP Annual Meeting
      2021 - 2022Dean's Teaching Excellence Award, The University of Texas Health Science Center at Houston, TX
      2021Best Case Report Poster Presentation, TSP Annual Meeting
      2021Best Investigative Poster Presentation, TSP Annual Meeting
      2017The Shannon Timmins Fellowship for Leukemia Research, The University of Texas MD Anderson Center
      2011Best Infectious Disease Presentation
      2011Best Infectious Disease Presentation Award, 100th Annual Meeting of USCAP, Binford-Dammin Society of Infectious Disease Pathologists
      2010Stowell-Orbison, Surgical Pathology and/or Autopsy Award (2nd Author), Annual Meeting of USCAP
      2003 - 2004Travel Award, The Shock Society, Annual Shock Conference
      2003Young Investigator Award, The Shock Society, Annual Shock Conference
      1996 - 1997Outstanding Young Researcher of the Year, Institute of Medico-Space Engineering
      1992Award for Outstanding Students, Bethune University of Medical Sciences

      Professional Memberships

      The College of American Pathology (CAP) peer inspection program

      2021

      The College of American Pathology (CAP) peer inspection program

      2021

      The College of American Pathology (CAP) peer inspection program

      2019

      Chinese American Pathologist Association

      2010 - Present

      College of American Pathologists

      2010 - Present

      United States and Canadian Academy of Pathology

      2009 - Present

      American Society of Clinical Pathology

      2007 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2018. Diagnostic Challenges and Updates in Hematopathology. Conference. The Alumni and Friends of the Department of Hematopathology. Houston, TX, US.

      Regional Presentations

      1. 2022. Interesting Case Presentation. Conference. Hematology Focus Interest Group (HFIG) Study, US.
      2. 2022. Interesting Case Presentation. Conference. Hematology Focus Interest Group (HFIG) Study, US.
      3. 2021. Interesting Case Presentation. Conference. Hematology Focus Interest Group (HFIG) Study, US.
      4. 2021. Pathology Grand Rounds talk - HIV-Associated Lymphomas. Conference. UTHealth, US.
      5. 2019. Interesting Case Presentation. Conference. Hematology Focus Interest Group (HFIG) Study, US.
      6. 2018. Interesting Case Presentation. Conference. Hematology Focus Interest Group (HFIG) Study, US.
      7. 2017. Interesting Case Presentation. Conference. Hematology Focus Interest Group (HFIG) Study, US.

      National Presentations

      1. 2022. Acute Myeloid Leukemia with Monocytic Differentiation, Marked Leukocytosis and Myeloperoxidase Expression Portends Poor Prognosis. Conference. CAP Annual Meeting. New Orleans, LA, US.
      2. 2022. High-Grade B-Cell Lymphoma with Effusion as The Initial Presentation. Conference. 2022 ASCP Annual Meeting. Chicago, IL, US.
      3. 2022. An Unusual Case of Thymic Castleman Disease with Calcifications. Conference. TSP Annual Meeting. Houston, TX, US.
      4. 2022. A 12-year Retrospective Study of 110 Patients with Central Nervous System Lymphomas from One Single Institution. Conference. TSP Annual Meeting. Houston, TX, US.
      5. 2022. Leukocytosis with Monocytosis on Peripheral Blood: A Diagnostic Clue for Acute Myeloid Leukemia with KMT2A (MLL) Gene Rearrangement. Conference. TSP Annual Meeting. Houston, TX, US.
      6. 2022. Amyloidosis Associated with Low-Grade B-Cell Lymphoma: A Report of 18 Cases. Conference. USCAP Annual Meeting. LA, CA, US.
      7. 2022. EBV-positive Diffuse Large B-cell Lymphomas of the CNS: A Report of 12 Cases. Conference. USCAP Annual Meeting. LA, CA, US.
      8. 2021. Peripheral T-Cell Lymphoma transformed from hydroa vacciniforme-like lymphoproliferative disorder. Platform Presentation. Conference. SH/EAHP Workshop - Virtual, US.
      9. 2021. Initial Classic Hodgkin Lymphoma and subsequent Diffuse Large B-Cell Lymphoma: separate entities with a continuum of BCL2 rearrangement. Platform presentation. Conference. SH/EAHP Workshop - Virtual, US.
      10. 2021. T-cell prolymphocytic leukemia with t(X;14)(q28;q11.2): a report of 17 cases. Conference. USCAP - Virtual, US.
      11. 2021. Acute myeloid leukemia and myelodysplastic syndrome with MYC rearrangement. Conference. USCAP Annual Meeting - Virtual, US.
      12. 2021. The diagnostic and prognostic roles of EBER for patients with HIV-associated aggressive non-Hodgkin lymphomas in the era of HAART. Platform presentation. Conference. USCAP - Virtual, US.
      13. 2020. Primary effusion lymphoma: a clinicopathological study of 29 cases. Conference. USCAP Annual Meeting. LA, CA, US.
      14. 2020. Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) with superimposed herpes simplex (HSV) lymphadenitis. Conference. TSP Annual Meeting. Dallas, TX, US.
      15. 2020. An Elderly Patient with Refractory Thrombocytosis and Transfusion Dependent Anemia. Conference. TSP Annual Meeting. Dallas, TX, US.
      16. 2019. Lymphocyte variant of hypereosinophilic syndrome. Platform Presentation. Conference. SH/EAHP Workshop, US.
      17. 2019. HIV-associated plasmablastic lymphoma: ten-year experience in the era of highly active antiretroviral therapy. Conference. USCAP Annual Meeting. Washington DC, US.
      18. 2019. High-Grade B-Cell Lymphoma is Associated with a Worse Survival than Other Aggressive B-Cell Lymphomas in HIV+ Patients. Conference. USCAP Annual Meeting. Washington DC, US.
      19. 2018. A multimodality work-up of patients with hypereosinophilia. Conference. USCAP Annual Meeting, US.
      20. 2017. 3q26.2/EVI1 rearrangements are associated with poor prognosis in Philadelphia chromosome-negative myeloproliferative neoplasms. Conference. USCAP Annual Meeting. San Antonio, TX, US.
      21. 2017. CD200 expression in mantle cell lymphoma correlates with absence of SOX11 expression and a leukemic presentation. Conference. USCAP Annual Meeting. San Antonio, TX, US.
      22. 2016. Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Platform Presentation. Conference. 18th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy. Houston, TX, US.
      23. 2016. Complex karyotypes predict a poorer prognosis in T-cell prolymphocytic leukemia. Conference. USCAP Annual Meeting. Seattle, WA, US.
      24. 2016. Mantle cell lymphoma with MYC rearrangement: best considered as a form of double hit lymphoma. Conference. USCAP Annual Meeting. Seattle, WA, US.
      25. 2015. Myeloid antigen expression in lymphoid blasts does not impact prognosis of acute lymphoblastic leukemia (ALL). Conference. USCAP Annual Meeting. Boston, MD, US.
      26. 2015. Depth of invasion: a reliable predictor of lymphadenectomy in FIGO grade II endometrial carcinoma patients. Conference. USCAP Annual Meeting. Boston, MA, US.
      27. 2013. Follicular T cell lymphomas frequently display an aberrant CD3-/CD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Conference. USCAP Annual Meeting. San Diego, CA, US.
      28. 2011. Measuring dimension of tumor invasion of urothelial carcinoma (UCa) in transurethral resection (TUR) predicts time of recurrence. Conference. USCAP Annual Meeting. San Antonio, TX, US.
      29. 2011. Transbronchial lung biopsy is not an optimal method for evaluating chronic rejection in lung transplant patients. Conference. USCAP Annual Meeting. San Antonio, TX, US.
      30. 2011. Comparison of infectious pathogen detection in pre- and postmortem specimens from lung transplant patients. Conference. USCAP Annual Meeting. San Antonio, TX, US.
      31. 2010. Increased length of survival after lung transplantation is not dependent on patient age at transplantation - analysis of 625 cases from a single center. Conference. USCAP Annual Meeting. Washington DC, US.
      32. 2010. Retrospective analysis of lung transplant patients between 1991-2009: improved survival is related to native lung disease. Conference. USCAP Annual Meeting. Washington DC, US.
      33. 2010. Medical complications in lung transplant patients - autopsy data from a single center. Conference. USCAP Annual Meeting. Washington DC, US.

      International Presentations

      1. 2022. Nodal marginal zone lymphoma with T-follicular helper expansion in a patient with a history of subcutaneous panniculitis-like T-cell lymphoma. Conference. EAHP-HP 2020 Workshop. Florence, IT.
      2. 2022. HHV8-negative primary effusion lymphoma in a patient with a liver transplant. Platform Presentation. Conference. EAHP-HP Workshop. Florence, IT.
      3. 2018. 3q26/EVI1 rearrangement in myelodysplastic/ myeloproliferative neoplasms: an early event associated with a poor prognosis. Conference. USCAP Annual Meeting. Vancouver, CA.
      4. 2012. Incidence of thyroid malignancy in completion thyroidectomy - a single institution experience over ten years. Conference. USCAP Annual Meeting. Vancouver, CA.
      5. 2012. The effect of general versus sub-specialty sign-out on the the reporting of lung transplant biopsy rejection. Conference. USCAP Annual Meeting. Vancouver, CA.
      6. 2012. Marrow hematogones as a percent of B-lymphocytes correlates with event-free survival (EFS) after allogeneic bone marrow transplant. Conference. USCAP Annual Meeting. Vancouver, CA.

      Formal Peers

      1. 2022. Diagnostic Challengers and Recent Updates in T-Cell Prolymphocytic Leukemia. Invited, US.
      2. 2021. Diagnostic Challengers and Recent Updates in T-Cell Prolymphocytic Leukemia. Invited, US.
      3. 2021. Diagnostic Challengers and Recent Updates in T-Cell Prolymphocytic Leukemia. Invited, US.
      4. 2018. HIV-Associated Aggressive B-Cell Lymphomas. Invited, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2015
      Title:Prognostic Implications of IGH Rearrangement in AML
      Funding Source:The University of Texas MD Anderson Cancer Center
      Role:Co-PI
      Date: 1999 - 2001
      Title:Pre-Doctoral Fellowship Grant
      Funding Source:Loyola University Medical Center
      Role:Student

      Selected Publications

      Peer-Reviewed Articles

      1. Shuai, W, Hu, Z, Yin, CC, Chen, L, Wang, W, Tang, G, Sui, D, Li, S, Xu, J, Ibrahim, NE, Pan, Z, You, MJ, Patel, KP, Vega Vazquez, F, Medeiros, LJ, Lin, P. Lowering the Diagnostic Threshold in Secondary Plasma Cell Leukemia? Comparison With Primary Cases and Implications for Flow Cytometry Immunophenotyping. Modern Pathology 39(2), 2026. e-Pub 2026. PMID: 41456722.
      2. Wang, WJ, Hu, Z, Gehris, BT, Naik, U, Bhattacharjee, M, Wahed, MA, Hu, S, You, MJ, Chen, L, Wang, W, Medeiros, LJ. Clinicopathological features of primary epidural B-cell lymphoma. Pathology 58(1):24-29, 2026. e-Pub 2026. PMID: 41062339.
      3. Chen, L, Ibrahim, NE, Tang, G, Meng, QH, Hu, Z. Aberrant Plasma Cells in the Absence of M-Protein. Clinical chemistry 71(12):1195-1199, 2025. e-Pub 2025. PMID: 41329021.
      4. Fitzpatrick, MJ, Yuan, J, Capa, I, Bledsoe, J, Kibler, CE, Tucker, C, Shuai, W, Matsumoto, NP, Zhu, GG, Ding, Y, Wu, X, Wang, W, Hu, Z, Jiang, L, Jia, Y, Zhao, Y, Lin, Y, Tian, X, Galliani, CA, Venkataraman, G, Mehrotra, S, Dal Cin, P, Haag, M, Siegele, B, Zhang, W, Wang, E, Castañeda-Sánchez, I, Zhang, Q, Perez-Atayde, AR, Young, KH, Sadigh, S, Wang, HY, Hasserjian, RP, Medeiros, LJ, Pan, Z. Erythroblastic Sarcoma in Adults and Children. Modern Pathology 38(8), 2025. e-Pub 2025. PMID: 40126459.
      5. Gao, Y, Ali, H, Hu, Z, Sun, H. Sarcoid-like Reaction in Breast Cancer Tumor Bed and Axillary Lymph Nodes Following Neoadjuvant Chemotherapy. Annals of clinical and laboratory science 55(2):281-285, 2025. e-Pub 2025. PMID: 40340873.
      6. Wang, WJ, Hu, Z. CD5-positive high-grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements. Blood 145(4):455, 2025. e-Pub 2025. PMID: 39847381.
      7. Sameeta, F, Wang, S, Tang, Z, Khoury, JD, Fang, H, Wang, D, Xu, J, Li, S, Hu, Z, Hu, S, Jorgensen, JL, Medeiros, LJ, Wang, W. Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. American journal of clinical pathology 162(5):455-463, 2024. e-Pub 2024. PMID: 38801226.
      8. Hu, Z, Ok, CY. Immature Erythroblasts in Pleural Effusion. Blood 144(7):794, 2024. e-Pub 2024. PMID: 39145944.
      9. Hu, Z, Ok, CY. Immature erythroblasts in pleural effusion. Blood 144(7):794, 2024. e-Pub 2024. PMID: 39145944.
      10. Rivera, D, Cui, W, Gao, J, Peker, D, Zhang, Q, Dewar, R, Qiu, L, Konoplev, SN, Hu, Z, Sasaki, K, Hu, AY, E, S, Liu, M, Fang, H, Wang, W, Tang, G, Apperley, JF, Hochhaus, A, Cortes, JE, Khoury, J, Medeiros, LJ, Jabbour, EJ, Hu, S. Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: a Report From the BCR::ABL1 Pathology Group. Modern Pathology 37(2), 2024. e-Pub 2024. PMID: 38104892.
      11. Al-Jumaili Z, Helen Zhang Y, Wang WJ, Mai B, Wang XI, Ahmed A, Wang W, Hu S, James You M, Hu Z. High-Grade B-Cell Lymphoma With Malignant Effusions as the Initial Presentation. Am J Clin Pathol 159(5):420-428, 2023. e-Pub 2023. PMID: 36879405.
      12. Hu, Z, Medeiros, LJ, Xu, M, Yuan, J, Peker, D, Shao, L, Tang, Z, Mai, B, Thakral, B, Rios, A, Hu, S, Wang, W. T-Cell Prolymphocytic Leukemia with t(X;14)(q28;q11.2). American journal of clinical pathology 159(4):325-336, 2023. e-Pub 2023. PMID: 36883805.
      13. Rivera, D, Wang, W, Al-Jumaili, Z, Hu, Z. Leukemic phase follicular lymphoma in a young adult. Journal of Clinical Laboratory Analysis 37(5), 2023. e-Pub 2023. PMID: 36930792.
      14. Wang W, Gehris BT, Mai B, Chen L, Hu S, You MJ, Hu Z. HHV8-Negative Effusion-Based lymphoma in a patient with recurrent HCV hepatitis status post liver transplantation. Leuk Lymphoma 63(14):3480-3483, 2022. e-Pub 2022. PMID: 36154351.
      15. Fang H, Wang SA, Khoury JD, El Hussein S, Kim DH, Tashakori M, Tang Z, Li S, Hu Z, Jelloul FZ, Patel KP, McDonnell TJ, Kadia T, Medeiros LJ, Wang W. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica 107(9):2232-2237, 2022. e-Pub 2022. PMID: 35511670.
      16. Wang X, Tang G, Hu Z, Fang H, Wang W, Tang Z, Toruner GA, Zhou T, DiNardo CD, Garcia-Manero G, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Hu S. Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survival. Br J Haematol 198(3):604-608, 2022. e-Pub 2022. PMID: 35645146.
      17. Fang H, Wang W, Zhang L, Shen Q, Yuan J, Reichard KK, Hu Z, Medeiros LJ. Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas. Am J Surg Pathol 46(3):326-335, 2022. e-Pub 2022. PMID: 34310368.
      18. Ricks E, Hu S, Hu Z. Cytokeratin-positive follicular dendritic cell sarcoma: A mimic of carcinoma. EJHaem 3(1):254-255, 2022. e-Pub 2022. PMID: 35846219.
      19. Ghosh A, Chen L, Wahed A, Wang W, Saluja K, Nguyen AND, Hu S, Hu Z. Incidental but rapidly progressing T-cell prolymphocytic leukemia with t(X;14)(q28;q11) involving parotid lymphoepithelial cysts: A diagnostic pitfall. Int J Lab Hematol 44(1):e17-e20, 2022. e-Pub 2022. PMID: 34275205.
      20. Xia M, Wu L, Sun X, Han X, Yan H, Huang J, Zhang Y, Hu Z, Zu Y, Yin CC, Qiu X. Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia. Biology (Basel) 11(2), 2022. e-Pub 2022. PMID: 35205028.
      21. Wang W, Hu Z. Leukocytosis with left-shifted myeloid maturation in a peripheral blood specimen: a clue to the lymphoid blast phase of CML. Blood 139(2):305, 2022. e-Pub 2022. PMID: 35024807.
      22. Mai B, Friscia M, Elzamly S, Thomas-Ogunniyi J, Wahed A, Nguyen A, Hu Z, Cai Z, Chen L. Obesity Is a Risk Factor Associated with H. pylori-negative MALT Lymphoma of Stomach. Ann Clin Lab Sci 51(5):609-614, 2021. e-Pub 2021. PMID: 34686502.
      23. Tang Y, Kortum A, Vohra I, Schwarz RA, Carns J, Kannady CR, Clavell-Hernandez J, Hu Z, Dhanani N, Richards-Kortum R. Initial Results of First In Vivo Imaging of Bladder Lesions Using a High-Resolution Confocal Microendoscope. J Endourol 35(8):1190-1197, 2021. e-Pub 2021. PMID: 33307957.
      24. Hu Z, Singhi EK, Apostolidou E, Mai B, Juneja HS, Hu S. Mass-forming neoplastic extramedullary hematopoiesis mimics myeloid sarcoma in a patient with chronic phase chronic myeloid leukemia. Int J Lab Hematol 43(3):e135-e137, 2021. e-Pub 2021. PMID: 33314782.
      25. Hu Z, Wang W, Thakral B, Chen Z, Estrov Z, Bueso-Ramos CE, Verstovsek S, Medeiros LJ, Wang SA. Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution. Cytometry B Clin Cytom 100(3):352-360, 2021. e-Pub 2021. PMID: 32157815.
      26. Hu Z, Pan Z, Chen W, Shi Y, Wang W, Yuan J, Wang E, Zhang S, Kurt H, Mai B, Zhang X, Liu H, Rios AA, Ma HY, Nguyen ND, Medeiros LJ, Hu S. Primary Effusion Lymphoma: A Clinicopathological Study of 70 Cases. Cancers (Basel) 13(4):1-14, 2021. e-Pub 2021. PMID: 33669719.
      27. Mai B, Wang W, Lin M, Hu S, Wang XI, Chen L, Wahed A, Nguyen A, Ma HY, Medeiros LJ, Hu Z. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients. AIDS 34(12):1735-1743, 2020. e-Pub 2020. PMID: 32889849.
      28. Dodge DL, Cherian SV, Ali YD, Murzabdillaeva A, Hu Z, Estrada-Y-Martin RM. A 35-Year-Old Woman With Progressive Dyspnea and Cough. Chest 158(3):e103-e106, 2020. e-Pub 2020. PMID: 32892884.
      29. Mai B, Wahed MA, Chen L, Nguyen ND, Wang XI, Hu Z. Educational Case: Systemic Mastocytosis with an Associated Hematological Neoplasm. Acad Pathol 7:2374289520906526, 2020. e-Pub 2020. PMID: 32158933.
      30. Mai B, Saluja K, Hu Z, Nguyen ND, Wahed A, Wang XI, Chen L. Educational Case: Mantle Cell Lymphoma. Acad Pathol 7:2374289520932286, 2020. e-Pub 2020. PMID: 32671196.
      31. Mai B, Wang W, Medeiros LJ, Ma HY, Hu Z. TdT-positive high grade B-cell lymphoma transformed from grade 3B follicular lymphoma in an HIV-positive patient. Pathology 51(7):764-768, 2019. e-Pub 2019. PMID: 31666176.
      32. El Achi H, Glass WF, Wang W, Medeiros LJ, Hu Z. Reactive lymphadenopathy with concurrent idiopathic plasma cell variant Castleman disease, amyloid deposition and non-caseating granulomas. Pathology 51(7):762-764, 2019. e-Pub 2019. PMID: 31662201.
      33. Jaitly V, Hu Z, Ayala G, Wahed MA, Nguyen ND, Brown RE. M2 Macrophages in Crystal Storing Histiocytosis Associated with Plasma Cell Myeloma. Ann Clin Lab Sci 49(5):666-670, 2019. e-Pub 2019. PMID: 31611212.
      34. Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. Am J Surg Pathol 43(5):710-716, 2019. e-Pub 2019. PMID: 30768440.
      35. Achi HE, Belousova T, Chen L, Wahed A, Wang I, Hu Z, Kanaan Z, Rios A, Nguyen AND. Automated Diagnosis of Lymphoma with Digital Pathology Images Using Deep Learning. Ann Clin Lab Sci 49(2):153-160, 2019. e-Pub 2019. PMID: 31028058.
      36. Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Xu J, Verstovsek S, Lin P. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis. Hum Pathol 85:290-298, 2019. e-Pub 2019. PMID: 30447300.
      37. Angelova EA, Medeiros LJ, Wang W, Muzzafar T, Lu X, Khoury JD, Ravandi F, Patel KP, Hu Z, Kanagal-Shamanna R. Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience. Mod Pathol 31(11):1717-1732, 2018. e-Pub 2018. PMID: 29955146.
      38. Hu Z, Boddu PC, Loghavi S, Miranda RN, Goswami M, Medeiros LJ, Tam W, Orazi A, Verstovsek S, Wang SA. A multimodality work-up of patients with Hypereosinophilia. Am J Hematol 93(11):1337-1346, 2018. e-Pub 2018. PMID: 30105844.
      39. Sun Y, Tang G, Hu Z, Thakral B, Miranda RN, Medeiros LJ, Wang SA. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia. J Clin Pathol 71(4):309-315, 2018. e-Pub 2018. PMID: 28821581.
      40. Quesada AE, Hu Z, Routbort MJ, Patel KP, Luthra R, Loghavi S, Zuo Z, Yin CC, Kanagal-Shamanna R, Wang SA, Jorgensen JL, Medeiros LJ, Ok CY. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing. Oncotarget 9(9):8441-8449, 2018. e-Pub 2018. PMID: 29492206.
      41. Hu Z, Hu S, Ji C, Tang Z, Thakral B, Loghavi S, Medeiros LJ, Wang W. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis. Leuk Res 65:25-28, 2018. e-Pub 2018. PMID: 29288910.
      42. Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Mod Pathol 31(2):327-336, 2018. e-Pub 2018. PMID: 28984300.
      43. Hu Z, Sun Y, Wang W, Medeiros LJ, Kanagal-Shamanna R. Refractory hairy cell leukemia-variant. Am J Hematol 92(12):1398-1399, 2017. e-Pub 2017. PMID: 27727469.
      44. Hu Z, Konoplev S. Aleukemic mast cell leukemia associated with chronic myelomonocytic leukemia and chronic lymphocytic leukemia. Blood 130(19):2150, 2017. e-Pub 2017. PMID: 29122774.
      45. Hu Z, Li S, Medeiros LJ, Sun T. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy. Hum Pathol 65:175-179, 2017. e-Pub 2017. PMID: 28232160.
      46. Hidalgo-López JE, Kanagal-Shamanna R, Quesada AE, Thakral B, Hu Z, Mitsuhashi T, Yabe M, Garcia-Manero G, Bueso-Ramos CE. Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints. Clin Lymphoma Myeloma Leuk 17S:S16-S25, 2017. e-Pub 2017. PMID: 28760297.
      47. Hu Z, Medeiros LJ, Wang W, Chen Z, Tang G, Hodjat P, Yang S, Fang L, Li Y, Verstovsek S, Hu S. 3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms. Mod Pathol 30(7):940-951, 2017. e-Pub 2017. PMID: 28338652.
      48. Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, Sun T, Quesada AE, Hu S, Wang SA, Pei L, Lu X. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia. Am J Hematol 92(5):441-447, 2017. e-Pub 2017. PMID: 28194886.
      49. Hu Z, Medeiros LJ, Chen Z, Chen W, Li S, Konoplev SN, Lu X, Pham LV, Young KH, Wang W, Hu S. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients. Am J Surg Pathol 41(2):216-224, 2017. e-Pub 2017. PMID: 27776009.
      50. Wang W, Chen Z, Hu Z, Yin CC, Li S, Bai S, Bueso-Ramos CE, Medeiros LJ, Hu S. Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Blood Cancer J 6(11):e490, 2016. e-Pub 2016. PMID: 27813536.
      51. Hu Z, Sun T. Blastic plasmacytoid dendritic cell neoplasm associated with chronic myelomonocytic leukemia. Blood 128(12):1664, 2016. e-Pub 2016. PMID: 28092882.
      52. McCroskey Z, Bahar B, Hu Z, Wojcik EM, Barkan GA. Subclassifying atypia in urine cytology: what are the helpful features?. J Am Soc Cytopathol 4(4):183-189, 2015. e-Pub 2015. PMID: 31051752.
      53. Hu Z, Mudaliar K, Quek ML, Paner GP, Barkan GA. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence. Ann Diagn Pathol 18(2):49-52, 2014. e-Pub 2014. PMID: 24370460.
      54. Bahar B, Hu Z, Szpaderska A, Liotta M, Potkul RK, Smith D, Ç E. Fatal case of luteinized thecoma with sclerosing peritonitis in a 40-year-old woman. Int J Gynecol Pathol 33(1):30-4, 2014. e-Pub 2014. PMID: 24300532.
      55. Pallikkuth S, Blackwell DJ, Hu Z, Hou Z, Zieman DT, Svensson B, Thomas DD, Robia SL. Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase. Biophys J 105(8):1812-21, 2013. e-Pub 2013. PMID: 24138857.
      56. Hou Z, Hu Z, Blackwell DJ, Miller TD, Thomas DD, Robia SL. 2-Color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding. PLoS One 7(7):e40369, 2012. e-Pub 2012. PMID: 22808146.
      57. Hu Z, Wang Y, Graham WV, Su L, Musch MW, Turner JR. MAPKAPK-2 is a critical signaling intermediate in NHE3 activation following Na+-glucose cotransport. J Biol Chem 281(34):24247-53, 2006. e-Pub 2006. PMID: 16793766.
      58. Hu Z, Sayeed MM. Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury. Am J Physiol Cell Physiol 288(5):C1171-8, 2005. e-Pub 2005. PMID: 15625305.
      59. Hu Z, Sayeed MM. Suppression of mitochondria-dependent neutrophil apoptosis with thermal injury. Am J Physiol Cell Physiol 286(1):C170-8, 2004. e-Pub 2004. PMID: 13679304.
      60. Hu Z, Zhao G, Xiao Z, Chen X, Zhong C, Yang J. Different responses of cerebral vessels to -30 degrees head-down tilt in humans. Aviat Space Environ Med 70(7):674-80, 1999. e-Pub 1999. PMID: 10417003.
      61. Zhao GX, Yang JS, Zhong CF, Lu LL, Hu ZH. [Star figure in medical monitoring during lower body negative pressure test]. Space Med Med Eng (Beijing) 12(2):101-5, 1999. e-Pub 1999. PMID: 12430534.
      62. Yang J, Zhao G, Zhong C, Hu Z, Lu L. [Heart rate variability analysis under lower body negative pressure]. Space Med Med Eng (Beijing) 11(6):430-4, 1998. e-Pub 1998. PMID: 11543380.
      63. Zhao G, Hu Z, Yang J, Zhong C. [Changes of cervical blood flow in subjects with different tolerances to -30 degrees head-down bed rest]. Space Med Med Eng (Beijing) 11(5):324-8, 1998. e-Pub 1998. PMID: 11543252.
      64. Hu Z, Zhao G, Yang J, Jiao J, Zhong C, Lu L. Linear and nonlinear analysis of heart rate variability during lower body negative pressure. Space Med Med Eng (Beijing) 11(4):235-9, 1998. e-Pub 1998. PMID: 11543238.
      65. Hu Z, Liu Y, Zhong C, Zhao G, Liu B. [Nonlinear dynamic analysis of heart rate variability during exercise]. Space Med Med Eng (Beijing) 11(2):111-5, 1998. e-Pub 1998. PMID: 11543226.

      Review Articles

      1. Rivera, D, Wang, WJ, Chan, KH, Ali, H, Wang, W, Medeiros, LJ, Hu, Z. From the archives of MD Anderson Cancer Center Castleman disease involving the thymus gland. Annals of Diagnostic Pathology 65, 2023. e-Pub 2023. PMID: 37060884.
      2. Li R, Saluja K, Lin M, Hu Z, Cai Z, Zhu H. Sinonasal Hamartomas: From Nasal Chondromesenchymal Hamartoma to Respiratory Epithelial Adenomatoid Hamartoma. Report of six Cases and Review of the Literature. Int J Surg Pathol 30(4):448-456, 2022. e-Pub 2022. PMID: 35001691.
      3. Hu Z, Chou PM, Jennings LJ, Arva NC. Infantile fibrosarcoma-a clinical and histologic mimicker of vascular malformations: case report and review of the literature. Pediatr Dev Pathol 16(5):357-63, 2013. e-Pub 2013. PMID: 23718697.

      Other Articles

      1. Rivera, D, Cui, W, Gao, J, Peker, D, Zhang, Q, Dewar, R, Qiu, L, Konoplev, SN, Hu, Z, Sasaki, K, Hu, AY, Shuyu, E, Liu, M, Fang, H, Wang, W, Tang, G, Apperley, JF, Hochhaus, A, Cortes, JE, Khoury, J, Medeiros, LJ, Jabbour, EJ, Hu, S Corrigendum to “Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group” [Modern Pathology. 2024;37(2):100406] (Modern Pathology (2024) 37(2), (S0893395223003113), (10.1016/j.modpat.2023.100406)). Modern Pathology 39(2), 2026. PMID: 41518888.

      Book Chapters

      1. Bittar EE, Khurana S. Mechanisms of ion transport and regulation by microfilaments. In: Advances in Molecular and Cell Biology: Aspects of the Cytoskeleton, 2006.

      Letters to the Editor

      1. Wang, X, Tang, G, Hu, Z, Medeiros, LJ, Hu, S. Splenic B-Cell Lymphoma/Leukemia With TCL1 Gene Rearrangement. International Journal of Laboratory Hematology 48: 683-688, 2026.
      2. Hu, Z, Yin, CC, Sun, X, Han, X, Wang, W, Wang, S, You, MJ. A diagnostic dilemma for a patient with skin lesions and marked leukocytosis. Pathology 57: 371-374, 2025.
      3. Gehris, BT, Wang, WJ, Mai, B, Chen, L, Wang, W, Hu, Z. Initial classic Hodgkin lymphoma and subsequent diffuse large B-cell lymphoma. Pathology 56: 115-118, 2024.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 14, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top